+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic factors in patients with inoperable non-small cell lung cancer--an analysis of long-term survival patients



Prognostic factors in patients with inoperable non-small cell lung cancer--an analysis of long-term survival patients



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(11): 1595-1602



A survival benefit of patients with inoperable non-small cell lung cancer has been reported since a development of new therapeutic agents in the 1990's. However, multivariate analyses of patients have not been evaluated. The aim of this study is to identify prognostic factors in the long-term survivors who had been treated with chemotherapy using these new agents and/or radiotherapy. A retrospective study and clinical analysis of 121 inoperable nonsmall cell lung cancer patients were conducted. Fifteen cases (male: 9, female: 6) with a survival of more than 2 years were revealed. Regarding clinical variables between the 15 cases and others, an early nodal (N) status, a high serum protein level, a good performance status (PS) and those having first-line chemotherapy or radiotherapy were all identified as significant prognostic factors for the long-term survivors. Multivariate analyses also revealed that an early N status, a good PS, female gender and chemotherapy and/or radiotherapy were associated with the long-term survivors. These results suggest that patients with inoperable non-small cell lung cancer should be considered for appropriate treatments including new chemotherapeutic agents.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050036215

Download citation: RISBibTeXText

PMID: 17108725


Related references

Analysis of prognostic factors for long term survival in patients with small cell lung cancer. Pneumonologia i Alergologia Polska 62(5-6): 233-238, 1994

Prognostic factors for survival in inoperable non-small-cell lung cancer: A multivariate regression analysis of 456 patients with radiation therapy. Onkologie 20(2): 126-131, 1997

Prognostic factors for long term survival in patients with advanced non-small cell lung cancer. Annals of Translational Medicine 4(9): 161, 2016

Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy. Strahlentherapie und Onkologie 190(12): 1125-1132, 2014

Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy. Journal of BUON 20(3): 775-781, 2015

Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. European Journal of Cardio-Thoracic Surgery 43(1): E17-E23, 2013

Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors. Bmc Cancer 15: 363, 2015

Long-term survival outcome of patients with inoperable non-small cell lung cancer (Nsclc) following concurrent chemoradiation therapy with oral etoposide and cisplatin. Lung Cancer 18: 88-89, 1997

Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery. Journal of Neurosurgery 102(Suppl.): 75-80, 2005

Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. Japanese Journal of Cancer Research 90(2): 249-253, 1999

Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. Strahlentherapie und Onkologie 190(1): 59-63, 2014

Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiotherapy and Oncology 15(3): 235-242, 1989

Factors associated with long-term survival of patients with advanced non-small cell lung cancer. Respirology 17(1): 134-142, 2012

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors. Lung Cancer 36(3): 313-319, 2002

Pretreatment prognostic factors for survival in non-small-cell lung cancer: A multivariate analysis of 229 patients. Onkologie 21(3): 204-210, 1998